# A Phase 1/2 Trial of PTR-01 in Adult Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)

> **NCT03752905** · PHASE1,PHASE2 · COMPLETED · sponsor: **Phoenix Tissue Repair, Inc.** · enrollment: 12 (actual)

## Conditions studied

- Recessive Dystrophic Epidermolysis Bullosa

## Interventions

- **DRUG:** PTR-01
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT03752905
- **Lead sponsor:** Phoenix Tissue Repair, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-09
- **Primary completion:** 2020-11-30
- **Final completion:** 2020-11-30
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2021-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03752905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03752905, "A Phase 1/2 Trial of PTR-01 in Adult Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03752905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*